Novel viral vectors in infectious diseases.
Since the development of Vaccinia virus as a vaccine vector in 1984, the utility of numerous viruses in vaccination strategies has been explored. In recent years, key improvements to existing vectors such as those based on adenovirus have led to significant improvements in immunogenicity and efficac...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2017
|
| _version_ | 1797093538464268288 |
|---|---|
| author | Humphreys, I Sebastian, S |
| author_facet | Humphreys, I Sebastian, S |
| author_sort | Humphreys, I |
| collection | OXFORD |
| description | Since the development of Vaccinia virus as a vaccine vector in 1984, the utility of numerous viruses in vaccination strategies has been explored. In recent years, key improvements to existing vectors such as those based on adenovirus have led to significant improvements in immunogenicity and efficacy. Furthermore, exciting new vectors that exploit viruses such as cytomegalovirus (CMV) and vesicular stomatitis virus (VSV) have emerged. Herein, we summarize these recent developments in viral vector technologies, focusing on novel vectors based on CMV, VSV, measles and modified adenovirus. We discuss the potential utility of these exciting approaches in eliciting protection against infectious diseases. This article is protected by copyright. All rights reserved. |
| first_indexed | 2024-03-07T04:01:57Z |
| format | Journal article |
| id | oxford-uuid:c4e1ecf7-b702-44aa-81e2-6461cd95136b |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:01:57Z |
| publishDate | 2017 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:c4e1ecf7-b702-44aa-81e2-6461cd95136b2022-03-27T06:26:49ZNovel viral vectors in infectious diseases.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c4e1ecf7-b702-44aa-81e2-6461cd95136bEnglishSymplectic Elements at OxfordWiley2017Humphreys, ISebastian, SSince the development of Vaccinia virus as a vaccine vector in 1984, the utility of numerous viruses in vaccination strategies has been explored. In recent years, key improvements to existing vectors such as those based on adenovirus have led to significant improvements in immunogenicity and efficacy. Furthermore, exciting new vectors that exploit viruses such as cytomegalovirus (CMV) and vesicular stomatitis virus (VSV) have emerged. Herein, we summarize these recent developments in viral vector technologies, focusing on novel vectors based on CMV, VSV, measles and modified adenovirus. We discuss the potential utility of these exciting approaches in eliciting protection against infectious diseases. This article is protected by copyright. All rights reserved. |
| spellingShingle | Humphreys, I Sebastian, S Novel viral vectors in infectious diseases. |
| title | Novel viral vectors in infectious diseases. |
| title_full | Novel viral vectors in infectious diseases. |
| title_fullStr | Novel viral vectors in infectious diseases. |
| title_full_unstemmed | Novel viral vectors in infectious diseases. |
| title_short | Novel viral vectors in infectious diseases. |
| title_sort | novel viral vectors in infectious diseases |
| work_keys_str_mv | AT humphreysi novelviralvectorsininfectiousdiseases AT sebastians novelviralvectorsininfectiousdiseases |